Inhibitory immunologicznych punktów kontrolnych podziału komórki w leczeniu chorób nowotworowych
Authors:
- Aleksandra MędraAMAleksandra Mędra
- Agata MajchrzakAMAgata Majchrzak
- Piotr SmolewskiPSPiotr Smolewski
- 1 April 2016
- journal article
- Published by Walter de Gruyter GmbH in Acta Haematologica Polonica
- Vol. 47 (2) , 155-162
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Inhibitory B7-family molecules in the tumour microenvironmentNature Reviews Immunology, 2008
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005
- Expression of Programmed Death 1 Ligands by Murine T Cells and APCThe Journal of Immunology, 2002
- Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte ActivationJournal of Experimental Medicine, 2000
- Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying ImmunoreceptorImmunity, 1999
- Immunoreceptor tyrosine-based inhibition motifsImmunology Today, 1997
- Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytesInternational Immunology, 1996
- Structure and Chromosomal Localization of the Human PD-1 Gene (PDCD1)Genomics, 1994